Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
News Beat March 2018
Share |


Seattle Science Foundation: Unraveling the Mysteries of the Spinal Cord


Life Science Washington is excited to share our day one keynote speaker at Life Science Innovation Northwest is Seattle Science Foundation. Drs. Rod Oskouian and Shane Tubbs of the Foundation are doing impressive work on a groundbreaking project to create a three-dimensional, open-source atlas of the human spinal cord. We interviewed Dr. Oskouian to garner pre-conference insight into their project and gain a sense of how this unique endeavor is progressing.



Seattle Science Foundation has undergone a metamorphosis in the last year or two. How has it changed your vision for the future?

The Seattle Science Foundation has experienced incredible growth in the last two years. Since its inception in 2006, the Foundation has made great strides in advancing patient care through our continuing medical education programs. In 2015, the Foundation implemented an anatomical research platform that would produce clinically relevant research designed to support our end goal of improving patient care. 


Pictured Dr. Rod Oskouian


Read the full story here



 Subscribing to News Beat        




We are proud to offer our month e-newsletter News Beat.To get member only content and savings, subscribe here


Have a story suggestion, funding opportunity, or upcoming event? Send it to us! Email Amanda Tran at


Planning to attend Life Science Innovation Northwest 2018? It's the biggest annual Life science event in the Pacific Northwest. Highlights include Startup Fast Pitch Showdown, Intern Speed Networking, The Hub, podium presentations, and more. Be part of the community. Register now.





 Welcome New Life Science Washington Members


  ABT 360, LLC          Controlled Contamination Svcs     Matheson Gas                             Stasys Medical                     University District Dev. Assoc.

  AgoaTech, LLC        CoVance                                            NanoSurface Biomedical           Steth IO

  Alcami                      Innoplexus Holdings                       Phase Genomics                         TransCellular Therapeutics




Opioid Crisis Update:
News on Alternatives


Grant Opportunity: The Distinguished Researchers Program

It's widely agreed that the opioid crisis is real and needs to be addressed. The question is how. 

As our society grapples with this issue, physicians and researchers are exploring non-opiod alternatives. Of note is this article from the Detroit Free Press. This white paper from AdvaMed highlights the wide range of devices that are already approved and in the market to help manage pain. We also want to share this report from BIO on the State of Innovation for Pain and Addiction Therapeutics.


While promising treatments are under development, the attention and resources dedicated to pain and addiction isn't the same as for other diseases that inflict a heavy toll on patients and society. Dr. Jeremy Levin outlines steps toward a solution in this op-ed published in the Morning Consult.

The Andy Hill Cancer Research Endowment is accepting applications for the second cohort of the Distinguished Researchers Program. The Distinguished Researchers Program matches, dollar for dollar, Washington research institutions’, organizations’, and commercial entities’ recruitment commitments up to $500,000 per recruitment, to add value to recruitment packages that bring leading cancer researchers to Washington. Andy Hill CARE grant funds may be used for any purpose (e.g., salaries, equipment, etc.) that advances the scholar’s research.
Please visit the Andy Hill CARE Fund website and the Distinguished Researchers page for a full program description and access to the application portal. The application period for the second cohort is February 15, 2018 to April 10, 2018.
Please contact Peter Choi ( with any questions regarding the program or application process.




From Laboratory to Leadership - 25 Anniversary Edition


It’s an incredibly exciting time for the life science industry. However, with this excitement comes stress, sweaty palms, sleepless nights, feelings of incompetence and increasing numbers of employee relations issues, as technically trained individuals find themselves promoted to management roles without any formal management or leadership training.

This is where From the Laboratory to Leadership can help.

Redesigned from the ground up, this 25th Anniversary Edition of the From Laboratory to Leadership program helps novice, life science managers develop their leadership skills and knowledge. The four-day program takes them from competent technical managers to capable business leaders. Leveraging knowledge gained over 25 years, the new edition gives participants the management foundation to successfully hire, develop, and deploy top talent in their organizations.

Whether you’re a start-up or fully integrated biopharmaceutical company, From the Laboratory to Leadership is a “game changer” for your employees and your organization. 

Interested? To learn more visit, The Leadership Edge website. Click here to register.





Life Science Washington Institute: Schedule your March consult


Life Science Washington Institute offers pro-bono consultation services to early-stage Member companies to help develop the Washington life science entrepreneurial community. A one-time consultation is available for future members. Our consultation program can help with a broad variety of issues facing the life sciences community. Learn More.



 Industry News


 The HPV vaccine: Preventing cancer beats treating it
The majority of cancers cannot presently be prevented, but some can. The primary example is cancers caused by human papilloma viruses (HPV). This thoughtful and provoking blog post by Stewart Lyman of Lyman BioPharma Consulting gives a first-hand perspective on the HPV vaccine debate  Read more on Stewart's blog.

UW, WSU collaborate on test for enhancing sleep
In the future, people struggling with insomnia might get health tips for a better night’s rest from a bedside sleep-monitoring device. Such technology will be tested in both Spokane and Seattle. The three-year study launched March 1. Read more in Spokane's Journal of Business

FDA must step up on rare diseases after cuts to Orphan Drug Tax Credit 
"In honor of Rare Disease Day. BIO President and CEO wrote the following op-ed. Jim highlights the biopharmaceutical industry’s ongoing efforts to tackle rare diseases." Read more from The Hill

PSBJ Innovator of the Year Award: Hacking cells at the Allen Institiute
"Paul Allen’s open-source research organization is paving the way for doctors to treat diseases like never before."  Read More from the Puget Sound Business Journal

Seattle Genetics Legacy of Partnering
"The CEO of Seattle Genetics discusses the past, present, and future of some of his company's partnerships.."  Read more from the Life Science Leader

Mind to Market: Filling a startup funding gap in Spokane
"A handful of Spokane-area investors, including a mix of organizations and individuals, has developed Mind to Market LLC to invest in early-stage startups—and to fill a gap in the region’s entrepreneurial ecosystem." Read more from Spokane's Journal of Business

Univ. of Washington teams Up with Pacific NW National Labs on materials science
"The University of Washington and Pacific Northwest National Laboratory are joining forces on a new research venture that spans 200 miles to advance the frontiers of materials science." Read more from GeekWire

Seattle biotech PhaseRx sold to Swiss buyer in bankruptcy case
"Seattle-based PhaseRx Inc. went public in May 2016 and filed for Chapter 11 bankruptcy protection in December 2017.." Read more from the Puget Sound Business Journal

Behind the deal: Risk and reward in Seattle Genetics' bid for Cascadian Therapeutics
"After failing to license a breast cancer drug last year, Seattle Genetics now has a deal to buy one. So why is Washington state's biggest biotech paying $614 million for a Seattle startup? Seattle Genetics has the experience to get Cascadian's drug to market." Read more from  the Puget Sound Business Journal



Networking and Development Opportunities



Call for Nominations: EY Entrepreneur of the Year Award 

If you have been inspired by a entrepreneur who breaks the mold, we’d like you to submit a nomination for the Entrepreneur Of The Year® Award, founded by EY. Since 1986, EY has celebrated the accomplishments of thousands of entrepreneurs who have shaped the way we live, work and play. Notable Pacific Northwest honorees include Chad and Harlan Robins, Adaptive Biotechnologies (2017), Hans Bishop, Juno Therapeutics (2016), Clay Siegall Ph.D., Seattle Genetics (2012) and Bruce Carter, ZymoGenetics (2003).

To learn more about the program, visit the website, or contact LSW member and EY Partner, Oren Lang-Furr 
Deadline to apply is March 9, 2018.









Membership Management Software Powered by YourMembership  ::  Legal